Yukiko Kataoka

Title: Innovations of Yukiko Kataoka

Introduction

Yukiko Kataoka is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of four patents to her name, her work has had a substantial impact on medical research and diagnostics.

Latest Patents

Among her latest patents is a monoclonal antibody that reacts with a glycopeptide. This glycopeptide contains a core fucose moiety and at least four contiguous amino acid residues located on the C-terminal side of a glycosylated asparagine moiety. The antibody recognizes both the core fucose moiety and an amino acid residue that is situated at least three amino acid residues away from the C-terminal of the glycosylated asparagine moiety. Another notable patent involves a reagent and reagent kit for the analysis of immature leukocytes, which provides essential tools for studying these cells in various medical contexts.

Career Highlights

Yukiko Kataoka is currently associated with Sysmex Corporation, a company known for its advanced diagnostic and laboratory solutions. Her work at Sysmex has allowed her to collaborate with other talented professionals in the field, enhancing the scope and impact of her inventions.

Collaborations

Some of her notable coworkers include Tomohiro Tsuji and Shinichiro Oguni, who have contributed to her research and development efforts. Their collaboration has fostered an environment of innovation and creativity, leading to groundbreaking advancements in biotechnology.

Conclusion

Yukiko Kataoka's contributions to the field of biotechnology through her patents and collaborations highlight her role as a leading inventor. Her work continues to influence medical research and diagnostics, showcasing the importance of innovation in improving healthcare outcomes.